World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
18641
World Ranking
2815
National Ranking
12

Penny L. Moore publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Penny L. Moore sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 205 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Penny L. Moore D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Penny L. Moore sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Penny L. Moore is affiliated with the National Health Laboratory Service in South Africa. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on Infectious Diseases, Virology, Molecular Biology, Immunology, and Radiology, Nuclear Medicine and Imaging.

The scientist's work covers several main topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • Monoclonal and Polyclonal Antibodies Research
  • Vaccines and Immunoinformatics Approaches
  • Vaccine Coverage and Hesitancy
  • Immune Cell Function and Interaction

They have contributed to a number of recent papers, notable among them are:

  • "Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant", 2021, New England Journal of Medicine
  • "SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma", 2021, Nature Medicine
  • "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization", 2021, Nature
  • "T cell responses to SARS-CoV-2 spike cross-recognize Omicron", 2022, Nature
  • "SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection", 2021, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors who have collaborated extensively with Penny L. Moore include:

  • Thandeka Moyo-Gwete
  • Simone I. Richardson
  • Tandile Hermanus
  • Prudence Kgagudi
  • Nelia P. Manamela

The scientist's publications have frequently appeared in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Virology
  • Frontiers in Immunology
  • Cell Host & Microbe
  • PLoS Pathogens

Best Publications

  • Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

    Unknown

  • SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

    Constantinos Kurt Wibmer;Frances Ayres;Tandile Hermanus;Mashudu Madzivhandila

  • Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.

    S. A. Madhi;V. Baillie;C. L. Cutland;M. Voysey

  • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

    Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  • T cell responses to SARS-CoV-2 spike cross-recognize Omicron

    Unknown

  • The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

    Elin S. Gray;Maphuti C. Madiga;Tandile. Hermanus;Penny L. Moore

  • SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

    Unknown

  • Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

    Constantinos Kurt Wibmer;Jinal N Bhiman;Elin S Gray;Nancy Tumba

  • Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

    Penny L. Moore;Emma T. Crooks;Lauren Porter;Ping Zhu

  • Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection

    E. S. Gray;P. L. Moore;I. A. Choge;J. M. Decker

  • Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

    Penny L. Moore;Elin S. Gray;C. Kurt Wibmer;C. Kurt Wibmer;Jinal N. Bhiman;Jinal N. Bhiman

  • SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape

    Unknown

  • The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines

    Unknown

  • Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.

    Penny L. Moore;Nthabeleng Ranchobe;Bronwen E. Lambson;Elin S. Gray

  • New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

    Nicole A. Doria-Rose;Jinal N. Bhiman;Jinal N. Bhiman;Ryan S. Roark;Chaim A. Schramm

  • Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

    Penny L Moore;Nthabeleng Ranchobe;Bronwen E Lambson;Elin S Gray

  • Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals

    Georgia D. Tomaras;James M. Binley;Elin S. Gray;Emma T. Crooks

  • Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies

    Jinal N. Bhiman;Jinal N. Bhiman;Colin. Anthony;Nicole A. Doria-Rose;Owen. Karimanzira

  • Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors

    Elin S. Gray;Natasha Taylor;Diane Wycuff;Penny L. Moore

  • Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

    Jason Gorman;Cinque Soto;Max M Yang;Thaddeus M Davenport

  • Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop

    Penny L. Moore;Elin S. Gray;Daniel Sheward;Maphuti C. Madiga

  • The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection

    Penelope L. Moore;Elin Solomonovna. Gray;Isaac Ang'Ang'A. Choge;Nthabeleng. Ranchobe

  • Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.

    Lingshu Wang;Tongqing Zhou;Yi Zhang;Eun Sung Yang

  • Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunization

    Cecilia Rademeyer;Bette Korber;Michael S Seaman;Elena E Giorgi

  • A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.

    Emma T. Crooks;Penny L. Moore;Michael Franti;Charmagne S. Cayanan

Frequent Co-Authors

Lynn Morris
Lynn Morris University of the Witwatersrand
Carolyn Williamson
Carolyn Williamson University of Cape Town
Salim S. Abdool Karim
Salim S. Abdool Karim Centre for the AIDS Programme of Research in South Africa
Jinal N. Bhiman
Jinal N. Bhiman University of the Witwatersrand
Elin S. Gray
Elin S. Gray Edith Cowan University
John R. Mascola
John R. Mascola ModeX Therapeutics
Philip J. R. Goulder
Philip J. R. Goulder University of Oxford
Lawrence Shapiro
Lawrence Shapiro Columbia University
Koleka Mlisana
Koleka Mlisana National Health Laboratory Service
Nicole A. Doria-Rose
Nicole A. Doria-Rose National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their knowledge in Immunology, exploring related fields like Psychiatric Mental Health Nurse Practitioner (PMHNP) programs can be highly beneficial. Many students seek reputable options, and the top pmhnp programs offer strong clinical placement rates to enhance practical experience.

Cost is often a major consideration, and individuals looking to expand their credentials without high expenses may find the cheapest pmhnp certificate programs valuable. These programs maintain solid quality while helping reduce financial barriers.

Career advancement through a Doctor of Nursing Practice (DNP) degree can also open doors to higher earning potential. Understanding the dnp salary by state helps prospective students assess potential return on their educational investment and plan their career path accordingly.

Many professionals consider transitioning between specialties, such as moving from a Family Nurse Practitioner (FNP) role to acute care. Guidance on obtaining the necessary credentials is available in resources outlining the acute care nurse practitioner certification, which helps streamline this shift for nurses seeking new clinical challenges.

Best Scientists Citing Penny L. Moore

Trending Scientists

Recently Published Articles